Seuraa
Walter Maetzler
Walter Maetzler
Prof. Dr. med.
Vahvistettu sähköpostiosoite verkkotunnuksessa neurologie.uni-kiel.de - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
MA Nalls, N Pankratz, CM Lill, CB Do, DG Hernandez, M Saad, ...
Nature genetics 46 (9), 989-993, 2014
19802014
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ...
Nature genetics 43 (7), 699-705, 2011
6112011
The release and trans-synaptic transmission of Tau via exosomes
Y Wang, V Balaji, S Kaniyappan, L Krüger, S Irsen, K Tepper, ...
Molecular neurodegeneration 12, 1-25, 2017
6032017
Technology in Parkinson's disease: challenges and opportunities
AJ Espay, P Bonato, FB Nahab, W Maetzler, JM Dean, J Klucken, ...
Movement Disorders 31 (9), 1272-1282, 2016
5962016
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies
MA Nalls, R Duran, G Lopez, M Kurzawa-Akanbi, IG McKeith, ...
JAMA neurology 70 (6), 727-735, 2013
4662013
Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases
M Bacioglu, LF Maia, O Preische, J Schelle, A Apel, SA Kaeser, ...
Neuron 91 (1), 56-66, 2016
4052016
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (vol 91, pg 56, 2016)
M Bacioglu, L Maia, O F. Preische, J Schelle, A Apel, S Kaeser, ...
Neuron 91 (2), 494-496, 2016
405*2016
Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy
S Lesage, V Drouet, E Majounie, V Deramecourt, M Jacoupy, A Nicolas, ...
The American Journal of Human Genetics 98 (3), 500-513, 2016
4042016
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
3962013
Progression of Parkinson's disease in the clinical phase: potential markers
W Maetzler, I Liepelt, D Berg
The Lancet Neurology 8 (12), 1158-1171, 2009
3942009
Quantitative wearable sensors for objective assessment of Parkinson's disease
W Maetzler, J Domingos, K Srulijes, JJ Ferreira, BR Bloem
Movement Disorders 28 (12), 1628-1637, 2013
3772013
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden, R Kraaij, J Jankovic, ...
Brain 140 (12), 3191-3203, 2017
3682017
BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls
C Laske, E Stransky, T Leyhe, GW Eschweiler, W Maetzler, A Wittorf, ...
Journal of psychiatric research 41 (5), 387-394, 2007
3412007
A Pan‐European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats
J van der Zee, I Gijselinck, L Dillen, T Van Langenhove, J Theuns, ...
Human mutation 34 (2), 363-373, 2013
3162013
A phase 2 trial of the GSK‐3 inhibitor tideglusib in progressive supranuclear palsy
E Tolosa, I Litvan, GU Höglinger, D Burn, A Lees, MV Andrés, ...
Movement Disorders 29 (4), 470-478, 2014
3062014
Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption
MC Cornelis, EM Byrne, T Esko, MA Nalls, A Ganna, N Paynter, ...
Molecular psychiatry 20 (5), 647-656, 2015
2812015
GBA‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study
K Brockmann, K Srulijes, S Pflederer, AK Hauser, C Schulte, W Maetzler, ...
Movement Disorders 30 (3), 407-411, 2015
2622015
A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson’s disease
C Godinho, J Domingos, G Cunha, AT Santos, RM Fernandes, D Abreu, ...
Journal of neuroengineering and rehabilitation 13, 1-10, 2016
2432016
A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson’s disease
C Godinho, J Domingos, G Cunha, AT Santos, RM Fernandes, D Abreu, ...
Journal of neuroengineering and rehabilitation 13, 1-10, 2016
2432016
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies
J Bras, R Guerreiro, L Darwent, L Parkkinen, O Ansorge, V Escott-Price, ...
Human molecular genetics 23 (23), 6139-6146, 2014
2432014
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20